BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12911044)

  • 1. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life.
    Mueller PS; Hook CC; Hayes DL
    Mayo Clin Proc; 2003 Aug; 78(8):959-63. PubMed ID: 12911044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.
    Kay GN; Bittner GT
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):336-9; discussion 339. PubMed ID: 19808484
    [No Abstract]   [Full Text] [Related]  

  • 3. Ethical analysis of withdrawing ventricular assist device support.
    Mueller PS; Swetz KM; Freeman MR; Carter KA; Crowley ME; Severson CJ; Park SJ; Sulmasy DP
    Mayo Clin Proc; 2010 Sep; 85(9):791-7. PubMed ID: 20584919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.
    Kapa S; Mueller PS; Hayes DL; Asirvatham SJ
    Mayo Clin Proc; 2010 Nov; 85(11):981-90. PubMed ID: 20843982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.
    Kramer DB; Kesselheim AS; Salberg L; Brock DW; Maisel WH
    Am J Cardiol; 2011 Apr; 107(7):1071-1075.e5. PubMed ID: 21296323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminalillness. Patient autonomy is paramount.
    Zellner RA; Aulisio MP; Lewis WR
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):340-4; discussion 340. PubMed ID: 19808485
    [No Abstract]   [Full Text] [Related]  

  • 7. Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life.
    Gura MT
    AACN Adv Crit Care; 2015; 26(4):356-63. PubMed ID: 26484996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac pacemakers and implantable defibrillators in terminal care.
    Braun TC; Hagen NA; Hatfield RE; Wyse DG
    J Pain Symptom Manage; 1999 Aug; 18(2):126-31. PubMed ID: 10484860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawing implantable defibrillator shock therapy in terminally ill patients.
    Lewis WR; Luebke DL; Johnson NJ; Harrington MD; Costantini O; Aulisio MP
    Am J Med; 2006 Oct; 119(10):892-6. PubMed ID: 17000222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pacemaker deactivation: withdrawal of support or active ending of life?
    Huddle TS; Amos Bailey F
    Theor Med Bioeth; 2012 Dec; 33(6):421-33. PubMed ID: 22351107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal of nonfutile life support after attempted suicide.
    Brown SM; Elliott CG; Paine R
    Am J Bioeth; 2013; 13(3):3-12. PubMed ID: 23428025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is pacemaker deactivation at the end of life unique? A case study and ethical analysis.
    Whitlock SN; Goldberg IP; Singh JP
    J Palliat Med; 2011 Oct; 14(10):1184-8. PubMed ID: 21882901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ethics of pacemaker deactivation in terminally ill patients.
    Bevins MB
    J Pain Symptom Manage; 2011 Jun; 41(6):1106-10. PubMed ID: 21621131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicolegal issues arising when pacemaker and implantable cardioverter defibrillator devices are deactivated in terminally ill patients.
    McGeary A; Eldergill A
    Med Sci Law; 2010 Jan; 50(1):40-4. PubMed ID: 20349694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes.
    Mueller PS; Jenkins SM; Bramstedt KA; Hayes DL
    Pacing Clin Electrophysiol; 2008 May; 31(5):560-8. PubMed ID: 18439169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deactivating cardiac pacemakers and implantable cardioverter defibrillators in terminally ill patients.
    Beca JP; Rosselot E; Asenjo R; Anguita V; Quevedo R
    Camb Q Healthc Ethics; 2009; 18(3):236-40. PubMed ID: 19460224
    [No Abstract]   [Full Text] [Related]  

  • 17. [Deactivating pacemakers in terminally ill patients].
    Hotvedt R
    Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1680. PubMed ID: 18704136
    [No Abstract]   [Full Text] [Related]  

  • 18. Withdrawal of cardiac medications and devices.
    Wiegand DL; Kalowes PG
    AACN Adv Crit Care; 2007; 18(4):415-25. PubMed ID: 17978616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features and outcomes of patients who underwent cardiac device deactivation.
    Buchhalter LC; Ottenberg AL; Webster TL; Swetz KM; Hayes DL; Mueller PS
    JAMA Intern Med; 2014 Jan; 174(1):80-5. PubMed ID: 24276835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defibrillator patients should not be denied a peaceful death.
    Westerdahl AK; Sutton R; Frykman V
    Int J Cardiol; 2015 Mar; 182():440-6. PubMed ID: 25597981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.